BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Receptor-interacting serine-threonine kinase 3 (RIPK3; RIP3); calcium calmodulin-dependent protein kinase II (CAMK2)

January 21, 2016 8:00 AM UTC

Cell culture and mouse studies suggest inhibiting RIPK3 or CAMK2 could help treat heart failure. Levels of RIPK3 and RIPK3-phosphorylated CAMK2 were higher in rat ventricular myocytes under hypoxic co...